/Companies

TBT Pharma

Baltimore, US · Founded 2019 · Delaware corporation · 1 known investors

Find your way into TBT Pharma

Sign up to see every warm intro you have to TBT Pharma

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the TBT Pharma team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

TBT Pharma is a biotech company developing repurposed generic drugs to replace topical steroids as the standard of care for skin conditions such as psoriasis, chronic wounds, and orphan skin diseases. Its approach relies on clinically validated data and exclusive patent licenses from NYU and Northwestern.

Founders & leadership

SG
Steve GirgentiNamed on SEC filing

Board

NCNeil Cohen
Neil CohenBoard directorFounder and Chairman at Emerald Development Managers
ITIan Tolfree
Ian TolfreeCEOPrincipal at Emerald Development Managers

Investors · 1

Reported raises · per SEC filings

Form D private placements

$700K disclosed across 1 round · 2020

▶$700KraisedJan 2021 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Neil CohenDirector
  • Ian TolfreeExecutive Officer, Director, Promoter
  • Steve GirgentiDirector
Offering amount
$2M
Amount sold
$700K
Minimum investment
$25K
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does TBT Pharma do?
TBT Pharma is a biotech company developing repurposed generic drugs to replace topical steroids as the standard of care for skin conditions such as psoriasis, chronic wounds, and orphan skin diseases. Its approach relies on clinically validated data and exclusive patent licenses from NYU and Northwestern.
Who are TBT Pharma's investors?
TBT Pharma's investors include Emerald Development Managers.
How much funding has TBT Pharma raised?
TBT Pharma has disclosed $700K raised across 1 round.
Where is TBT Pharma headquartered?
TBT Pharma is headquartered in Baltimore, US.